Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
36.25M | 36.36M | 37.47M | 59.90M | 74.63M | Gross Profit |
2.55M | 8.87M | 2.66M | 10.42M | 12.85M | EBIT |
2.55M | 1.93M | -6.69M | -10.41M | -10.68M | EBITDA |
107.00K | -13.03M | -15.42M | -8.23M | 5.60M | Net Income Common Stockholders |
-8.31M | -15.35M | -33.64M | -18.61M | -16.39M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
815.00K | 6.18M | 1.74M | 17.27M | 25.61M | Total Assets |
27.34M | 35.93M | 38.93M | 77.69M | 90.83M | Total Debt |
9.12M | 5.42M | 5.84M | 12.38M | 24.83M | Net Debt |
8.31M | -770.00K | 4.11M | -4.90M | -775.00K | Total Liabilities |
17.83M | 18.11M | 18.57M | 36.94M | 33.53M | Stockholders Equity |
9.51M | 17.82M | 20.36M | 40.75M | 57.30M |
Cash Flow | Free Cash Flow | |||
-2.16M | -5.39M | 1.94M | -5.66M | -17.31M | Operating Cash Flow |
-2.16M | -4.59M | 2.01M | -3.34M | -15.51M | Investing Cash Flow |
13.00K | -797.00K | -258.00K | -2.10M | -1.42M | Financing Cash Flow |
-3.22M | 9.84M | -17.29M | -2.89M | -15.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $6.86B | 11.07 | 2.77% | 4.27% | 2.66% | -24.95% | |
47 Neutral | HK$61.33M | ― | -60.82% | ― | -1.71% | 39.00% | |
$2.89B | 56.37 | 2.23% | 2.98% | ― | ― | ||
― | ― | ― | ― | ||||
78 Outperform | HK$2.55B | 5.33 | 49.10% | 3.73% | 3.11% | -2.34% | |
69 Neutral | HK$4.30B | 8.18 | 12.09% | 7.65% | 23.94% | -9.82% | |
13.19 | 4.25% | ― | ― |